Hinge Health (NYSE:HNGE) Sees Large Volume Increase - Here's What Happened

Key Points

• Hinge Health saw trading volume surge to 1,456,380 shares—a 30% increase from the prior session—and was trading around $50.34 midday, up from a $48.89 close.
• The company beat quarterly expectations, reporting $0.49 EPS versus a $0.04 estimate and $170.73 million in revenue (up 45.5% year‑over‑year) versus a $157.31 million consensus.
• Analysts have a consensus rating of Moderate Buy with a consensus target price of $56.73, while individual targets cited in recent reports range roughly from $52 to $68.

Hinge Health Inc. (NYSE:HNGE - Get Free Report) saw an uptick in trading volume on Tuesday . 1,456,380 shares were traded during mid-day trading, an increase of 30% from the previous session's volume of 1,123,016 shares.The stock last traded at $50.3360 and had previously closed at $48.89.

Analyst Ratings Changes

HNGE has been the subject of a number of research reports. Wells Fargo & Company started coverage on Hinge Health in a research report on Thursday, January 8th. They set an "overweight" rating and a $68.00 price objective for the company. Stifel Nicolaus set a $59.00 target price on shares of Hinge Health in a research report on Thursday, February 5th. Barclays dropped their price target on shares of Hinge Health from $60.00 to $52.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 11th. Needham & Company LLC reissued a "buy" rating and set a $59.00 price objective on shares of Hinge Health in a research report on Wednesday, February 11th. Finally, Citizens Jmp reissued a "market outperform" rating and set a $65.00 target price on shares of Hinge Health in a research report on Wednesday, February 11th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Hinge Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $56.73.

Hinge Health Price Performance

The firm's 50 day moving average price is $42.03 and its 200-day moving average price is $43.94. The firm has a market cap of $4.12 billion and a price-to-earnings ratio of -4.08.

Hinge Health (NYSE:HNGE - Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.45. The business had revenue of $170.73 million during the quarter, compared to the consensus estimate of $157.31 million. The company's revenue for the quarter was up 45.5% on a year-over-year basis. Analysts expect that Hinge Health Inc. will post 0.78 EPS for the current year.

Insider Activity at Hinge Health

In related news, President James Pursley sold 15,000 shares of the company's stock in a transaction dated Monday, March 23rd. The shares were sold at an average price of $42.26, for a total value of $633,900.00. Following the transaction, the president owned 732,104 shares in the company, valued at approximately $30,938,715.04. This represents a 2.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Daniel Antonio Perez sold 166,665 shares of the company's stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $40.26, for a total transaction of $6,709,932.90. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 442,670 shares of company stock worth $18,786,901. 18.92% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Hinge Health

A number of institutional investors have recently modified their holdings of HNGE. Wells Fargo & Company MN grew its stake in Hinge Health by 160.0% during the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company's stock worth $25,000 after buying an additional 336 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in Hinge Health in the fourth quarter worth $26,000. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Hinge Health during the 3rd quarter worth about $37,000. CENTRAL TRUST Co bought a new position in shares of Hinge Health in the first quarter valued at approximately $37,000. Finally, First Horizon Corp grew its holdings in shares of Hinge Health by 163.9% in the fourth quarter. First Horizon Corp now owns 855 shares of the company's stock valued at $40,000 after acquiring an additional 531 shares in the last quarter.

Hinge Health Company Profile

Hinge Health NYSE: HNGE is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.